These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25414810)

  • 1. Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.
    Vadlapudi AD; Patel A; Cholkar K; Mitra AK
    Recent Pat Biomed Eng; 2012 Apr; 5(1):83-101. PubMed ID: 25414810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Patents and Emerging Therapeutics on Ocular Inflammation and Allergy.
    Agrahari V; Aulgur Z; Thukral S; Dhall N; Conley R; Mitra AK
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):92-106. PubMed ID: 28901856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
    Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
    Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD).
    Nashine S
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].
    Tamaki Y
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uveitis, the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT), and intravitreal biologics for ocular inflammation.
    Yeh S; Albini TA; Moshfeghi AA; Nussenblatt RB
    Am J Ophthalmol; 2012 Sep; 154(3):429-435.e2. PubMed ID: 22898344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New ocular therapeutics: a view from the patenting perspective.
    Mucke HA
    IDrugs; 2007 Jan; 10(1):37-41. PubMed ID: 17187313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging innovations in nano-enabled therapy against age-related macular degeneration: A paradigm shift.
    Kumar Dubey S; Pradhan R; Hejmady S; Singhvi G; Choudhury H; Gorain B; Kesharwani P
    Int J Pharm; 2021 May; 600():120499. PubMed ID: 33753164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in measurement of ocular blood flow and relevance to our understanding of glaucoma and age-related macular degeneration.
    Harris A; Chung HS; Ciulla TA; Kagemann L
    Prog Retin Eye Res; 1999 Sep; 18(5):669-87. PubMed ID: 10438154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Treatments for Age-Related Macular Degeneration: A Review of Clinical Advances in Sustained Drug Delivery Systems.
    Jiménez-Gómez Y; Alba-Molina D; Blanco-Blanco M; Pérez-Fajardo L; Reyes-Ortega F; Ortega-Llamas L; Villalba-González M; Fernández-Choquet de Isla I; Pugliese F; Stoikow I; González-Andrades M
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review on recent drug delivery systems for posterior segment of eye.
    Nayak K; Misra M
    Biomed Pharmacother; 2018 Nov; 107():1564-1582. PubMed ID: 30257375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Gut-Eye Axis: An Emerging Strategy to Face Ocular Diseases.
    Campagnoli LIM; Varesi A; Barbieri A; Marchesi N; Pascale A
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do Oral Pathogens Inhabit the Eye and Play a Role in Ocular Diseases?
    Arjunan P; Swaminathan R
    J Clin Med; 2022 May; 11(10):. PubMed ID: 35629064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography for age-related macular degeneration and diabetic macular edema: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(13):1-22. PubMed ID: 23074517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye.
    Cheng KJ; Hsieh CM; Nepali K; Liou JP
    J Med Chem; 2020 Oct; 63(19):10533-10593. PubMed ID: 32482069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promising therapeutic drug delivery systems for glaucoma: a comprehensive review.
    Singh RB; Ichhpujani P; Thakur S; Jindal S
    Ther Adv Ophthalmol; 2020; 12():2515841420905740. PubMed ID: 32206746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin: Implications for Ocular Disease and Therapeutic Potential.
    Scuderi L; Davinelli S; Iodice CM; Bartollino S; Scapagnini G; Costagliola C; Scuderi G
    Curr Pharm Des; 2019; 25(39):4185-4191. PubMed ID: 31724508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota and Ocular Diseases.
    Xue W; Li JJ; Zou Y; Zou B; Wei L
    Front Cell Infect Microbiol; 2021; 11():759333. PubMed ID: 34746029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration.
    Yeong JL; Loveman E; Colquitt JL; Royle P; Waugh N; Lois N
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013154. PubMed ID: 33331670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Macular choroidal blood flow in concurrent age-related macular degeneration and primary open-angle glaucoma].
    Panova IE; Ermak EM; Shaimova TA; Shaimova VA
    Vestn Oftalmol; 2016; 132(4):48-53. PubMed ID: 27600895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.